Compass Therapeutics (CMPX) Invested Capital (2019 - 2021)

Compass Therapeutics (CMPX) has 3 years of Invested Capital data on file, last reported at $3.7 million in Q3 2021.

• For the quarter ending Q3 2021, Invested Capital fell 49.82% year-over-year to $3.7 million; the trailing twelve-month figure through Jun 2022 stood at $3.7 million (down 83.29% YoY), and the FY2020 full-year result was $7.5 million, up 33.91% from the prior year.
• Invested Capital eased to $3.7 million in Q3 2021, from $7.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $7.5 million in Q1 2021 to a low of $3.7 million in Q3 2021.
• A 3-year average of $6.5 million and a median of $7.5 million in 2020 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital jumped 33.91% in 2020 and tumbled 49.82% in 2021, its largest moves.
• Tracing CMPX's Invested Capital over 3 years: stood at $5.6 million in 2019, then jumped by 33.91% to $7.5 million in 2020, then tumbled by 49.86% to $3.7 million in 2021.
• Business Quant data shows CMPX's Invested Capital at $3.7 million in Q3 2021, $7.5 million in Q1 2021, and $7.5 million in Q4 2020.